<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Mirapexin preparations; Pramipexole" /><meta name="IX" content="Mirapexin preparations; Pramipexole" /><title>Mirapexin®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="77551.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="77551.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=77551.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2055.htm">4 Central nervous system</a> &gt; <a href="3631.htm">4.9 Drugs used in parkinsonism and related disorders</a> &gt; <a href="3632.htm">4.9.1 Dopaminergic drugs used in Parkinson’s disease</a> &gt; <a href="129827.htm">Dopamine-receptor agonists</a> &gt; <a href="77550.htm">PRAMIPEXOLE</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="3650.htm" title="Previous: PERGOLIDE">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="57171.htm" title="Next: ROPINIROLE">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a397029.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pramipexole Dihydrochloride</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Central Nervous System Agents 28:00 &gt; Antiparkinsonian Agents 28:36 &gt; Dopamine Receptor Agonists 28:36.20 &gt; Nonergot-derivative Dopamine Receptor Agonists 28:36.20.08</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/5570-t.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Pramipexole</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: P &gt; Interactions of Pramipexole</p></div></li></ul><ul><li><h3>British National Formulary (6)</h3></li><li><a href="129827.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Dopamine-receptor agonists</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.9 Drugs used in parkinsonism and related disorders &gt; 4.9.1 Dopaminergic drugs used in Parkinson’s disease</p></div></li><li><a href="77550.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">PRAMIPEXOLE</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.9 Drugs used in parkinsonism and related disorders &gt; 4.9.1 Dopaminergic drugs used in Parkinson’s disease &gt; Dopamine-receptor agonists</p></div></li><li><a href="215613.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pramipexole</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.9 Drugs used in parkinsonism and related disorders &gt; 4.9.1 Dopaminergic drugs used in Parkinson’s disease &gt; Dopamine-receptor agonists &gt; PRAMIPEXOLE</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22pramipexole%22%22pramipexole%22%22restless+legs+syndrome%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (6)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK1367.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pramipexole</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; P</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/19970-j.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pramipexole Hydrochloride</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antiparkinsonian Drugs &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/7000-a6-10-h.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Sleep-associated movement disorders</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Anxiolytic Sedatives Hypnotics and Antipsychotics &gt; Introduction &gt; Sleep disorders</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/07705.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pramipexole</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; P &gt; PR</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E6E3E0R0D1266.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Pramipexole</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; P</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_77550">PRAMIPEXOLE</h1><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i881.htm" title="Go to appendix 1">Pramipexole</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">Parkinson’s disease, used alone or
as an adjunct to co-beneldopa
or co-careldopa; moderate to severe restless legs syndrome</p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF">see <a title="monograph-family: Dopamine receptor agonists" href="129827.htm#_129827">notes above</a>; psychotic disorders; ophthalmological
testing recommended (risk of visual disorders); severe cardiovascular disease; risk of
postural hypotension (especially on initiation)—monitor blood pressure; <b>interactions:</b> Appendix 1 (<span>pramipexole</span>)</p></div><div class="cAF"><h2>Renal impairment</h2> <ul class="cBF"><li><p class="cQ">for <i>immediate-release</i> tablets in Parkinson’s
disease, initially 88 micrograms twice daily (max. 1.57 mg daily in
2 divided doses) if eGFR 20–50 mL/minute/1.73m<sup>2</sup>; initially
88 micrograms once daily (max. 1.1 mg once daily) if eGFR less than
20 mL/minute/1.73 m<sup>2</sup>; if renal function declines during
treatment, reduce dose by the same percentage as the decline in eGFR</p></li><li><p class="cQ">for <i>immediate-release</i> tablets in restless
legs syndrome, reduce dose if eGFR less than 20 mL/minute/1.73 m<sup>2</sup></p></li><li><p class="cQ">for <i>modified-release</i> tablets, initially
260 micrograms on alternate days if eGFR 30–50 mL/minute/1.73m<sup>2</sup>, increased to 260 micrograms once daily after 1 week, further
increased if necessary by 260 micrograms daily at weekly intervals
to max. 1.57 mg daily; avoid if eGFR less than 30 mL/minute/1.73m<sup>2</sup></p></li></ul></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">use only if potential benefit outweighs risk—no information
available</p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">may suppress lactation; avoid—present in milk
in <i>animal</i> studies</p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">see <a title="monograph-family: Dopamine receptor agonists" href="129827.htm#_129827">notes above</a>; also
nausea, constipation, vomiting, weight changes, decreased appetite,
hypotension (including postural hypotension), peripheral oedema, dizziness,
dyskinesia, hyperkinesia, drowsiness (including <a title="BNF:target-block: Dopamine receptor agonists and driving" href="129827.htm#_213600">sudden onset of sleep</a>),
headache, sleep disturbances, confusion, hallucinations, restlessness,
visual disturbances; <i>less commonly</i> hiccups, cardiac
failure, syncope, pneumonia, dyspnoea, binge eating, compulsive behaviour
(see <a title="BNF:target-text: Impulse control disorder caution" href="129827.htm#_211435">notes above</a>), amnesia,
delusion, paranoia, pruritus, rash; <i>also reported</i> paradoxical worsening of restless legs syndrome</p></div><div class="cAF"><h2>Dose</h2> <div class="cAT"><h3>Important</h3> <p class="cAX">Doses and strengths are stated in terms
of <span>pramipexole</span> (base); equivalent strengths in
terms of <span>pramipexole</span> dihydrochloride monohydrate
(salt) are as follows: <br />88 micrograms base ≡ 125 micrograms
salt; <br />180 micrograms base ≡ 250 micrograms salt; <br />350 micrograms base ≡ 500 micrograms salt;<br />700 micrograms
base ≡ 1 mg salt</p></div><p class="cR">Parkinson’s disease, <span class="cAK">adult</span> over
18 years, initially 88 micrograms 3 times daily, dose doubled every
5–7 days if tolerated to 350 micrograms 3 times daily; further increased
if necessary by 180 micrograms 3 times daily at weekly intervals;
max. 3.3 mg daily in 3 divided doses</p><div class="cAT"><h3>Note</h3> <p class="cAX">During dose titration and maintenance, <span>levodopa</span> dose may be reduced</p></div><p class="cR">Restless legs syndrome, <span class="cAK">adult</span> over 18 years, initially 88 micrograms once daily 2–3 hours before
bedtime, dose doubled every 4–7 days if necessary; max. 540 micrograms
daily</p></div><div class="cAV"><h3>Note</h3> <p class="cAX">Repeat dose titration if restarting treatment
after an interval of more than a few days</p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="215613.htm#_215613" title="Pramipexole">Pramipexole</a></li><li class="jN" id="_77551" style="margin: 0 0 0 20px;"><h1 class="title">Mirapexin®<span> (<a href="appendix-112803-B.htm#m39">Boehringer Ingelheim</a>)</span> <img class="cJ" src="images/pom_l.png" title="Prescription-only Medicine" alt="Prescription-only Medicine" /></h1><div class="cAY"><span class="cAB">Tablets</span>, <span>pramipexole</span> 88 micrograms, net price 30-tab pack = £9.55; 180 micrograms (scored),
30-tab pack = £19.10, 100-tab pack = £63.67; 350 micrograms (scored),
30-tab pack = £38.20, 100-tab pack = £127.34; 700 micrograms (scored),
30-tab pack = £76.40, 100-tab pack = £254.69. 
    Label:
    10, counselling, driving, see <a title="BNF:target-block: Dopamine receptor agonists and driving" href="129827.htm#_213600">notes above</a></div></li><li id="_204131__204131"><a href="204131.htm#_204131" title="Modified release">Modified release</a><ul style="display: none"><li><a href="204132.htm#_204132" title="Mirapexin® Prolonged Release">Mirapexin® Prolonged Release</a></li></ul></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="3650.htm">Previous: PERGOLIDE</a> | <a class="top" href="77551.htm#">Top</a> | <a accesskey="]" href="57171.htm">Next: ROPINIROLE</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>